• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconDrugs

Drugs

Page 29 of 31
PA: Mylan Headquarters
FinanceMylan goes big with $29 billion offer to buy Perrigo
By Laura LorenzettiApril 8, 2015
States ask U.S. Congress to launch inquiry of herbal supplements
RetailStates ask U.S. Congress to launch inquiry of herbal supplements
By ReutersApril 2, 2015
IL: Corporations In Illinois
FeaturesTakeda’s ready to shell out $2.2 billion to settle Actos drug cases
By Laura LorenzettiApril 1, 2015
Where do CEOs with addictions go when they hit bottom?
LeadershipWhere do CEOs with addictions go when they hit bottom?
By Daniel BukszpanMarch 25, 2015
Merck
FeaturesMerck halts study in light of melanoma drug’s success
By Laura LorenzettiMarch 24, 2015
George Scangos, CEO of Biogen Inc. speaks during Reuters Health Summit in New York
FeaturesHow Biogen scored the most successful Alzheimer’s drug so far
By Jen WiecznerMarch 20, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
FinanceValeant comes out a winner after upping its Salix bid to $11.1 billion
By Laura LorenzettiMarch 16, 2015
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
FeaturesFDA approves the first biosimilar for the U.S. market
By Laura LorenzettiMarch 6, 2015
IL: Corporations In Illinois
FinanceAbbVie to buy cancer drug maker Pharmacyclics in $21 billion deal
By ReutersMarch 4, 2015
Inside Rite Aid Ahead of Earnings Reports
RetailRite Aid takes aim at CVS with a $2 billion purchase
By Laura LorenzettiFebruary 11, 2015
161135392
FeaturesBiosimilars may one day save your life. But what are they?
By Laura LorenzettiFebruary 6, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
FinanceAfter Allergan loss, is Valeant dumpster diving?
By Jen WiecznerJanuary 31, 2015
Picture taken on January 15, 2012 in Lil
CommentaryHow to stop generic drug shortages: end hospital group purchasing kickbacks 
By Phillip L. Zweig and Robert A. CampbellJanuary 30, 2015
Los Angeles City Council Votes To Ban Medical Marijuana Dispensaries
RetailReport predicts 18 states will legalize pot by 2020
By TIMEJanuary 26, 2015
Regeneron vaults ahead of Amgen in race to market cholesterol drug
FeaturesRegeneron vaults ahead of Amgen in race to market cholesterol drug
By ReutersJanuary 26, 2015
1...
  • 27
  • 28
  • 29
  • 30
  • 31
31
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Elon Musk on MacKenzie Scott giving away $26 billion of her fortune: 'Sadly,' it makes the world a worse placeplaceholder alt text
By Sydney LakeJune 29, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.